Best Crl Podcasts (2025)

1
Insights from Pharma and Biotech: CRL Transparency, Acquisition Updates, and Digitization Strategies 1:28

Play Pause

5d ago1:28

1:28

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The FDA has recently released over 200 complete response letters (CRLs) as part of its initiative to enhance transparency regarding the reasons behind the rejection of new drug and biologics applications. This effort reflec…

1
Pharma and Biotech Daily: Your Morning Dose of Industry Updates 1:06

1h ago1:06

1:06

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The U.S. Department of Health and Human Services (HHS) has begun formally laying off thousands of employees following a Supreme Court ruling allowing the Trump administration to reorganize the agency. FDA Commissioner Mar…

1
Pharma and Biotech Daily: Navigating the Latest in Drug Development and Innovation 2:11

1d ago2:11

2:11

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Takeda has taken the lead in the race for a narcolepsy treatment with back-to-back phase III wins for their drug Oveporexton. Investors are eagerly awaiting breakthroughs in using psychedelics to treat depression. Ultragen…

1
Pharma and Biotech Daily: FDA Rejections, Vaccine Approvals, and Industry Acquisitions 1:01

2d ago1:01

1:01

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The FDA has rejected Capricor's therapy for Duchenne Muscular Dystrophy (DMD), causing shares to plunge due to insufficient evidence of effectiveness for cardiomyopathy associated with DMD. Lilly and Sarepta also received…

1
Pharma and Biotech Daily: Merck's Acquisition, Supreme Court Ruling, and Trump's Tariff Threats 1:04

6d ago1:04

1:04

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Merck recently made a significant move in the pharmaceutical industry by acquiring Verona for $10 billion, gaining access to the commercial COPD drug Ohtuvayre. This acquisition is viewed as a strategic decision to offse…

1
Pharma and Biotech Daily: Legal Battles, Acquisitions, Policy Changes, and Innovation 1:11

7d ago1:11

1:11

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Medical societies, including the American Academy of Pediatrics, have filed a lawsuit against RFK Jr. over changes to COVID-19 vaccine policies. They argue that his directive to remove COVID-19 from vaccination guidelines…

1
Pharma and Biotech Daily: Latest in Drug Approvals, Biopharma Milestones, and Industry Trends 1:17

8d ago1:17

1:17

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Kalvista has received approval for the first on-demand hereditary angioedema pill after facing challenges with the FDA. Meanwhile, Robert F. Kennedy Jr. has made significant cuts and rehires at the Department of Health an…

1
Pharma and Biotech Daily: Keeping You Informed on the Latest Advancements 2:08

9d ago2:08

2:08

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Breakthrough in Cancer TreatmentExciting news in the world of oncology as a new breakthrough in cancer treatment has been announced. Researchers have discovered a novel therapy that targets specific mutations in cancer…

1
Pharma and Biotech Daily: RSV Vaccine Expansion, Biogen's Deal Struggle, and More! 0:51

12d ago0:51

0:51

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people aged 50-59 who are at risk of severe disease, following recommendations from ACIP members he had previously fired. Biogen CEO Ch…

1
Pharma and Biotech Daily: M&A Surge and Regulatory Updates in the Industry 1:29

13d ago1:29

1:29

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. A judge has suspended mass layoffs at the Department of Health and Human Services, ruling that the staff cuts are likely unlawful as the agency does not have the authority to make such changes without Congress. In other …

1
The Pharma and Biotech Daily: Beckley's Nasal Spray Success, M&A Activity Surge, and Job Opportunities 1:14

14d ago1:14

1:14

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Beckley's psychedelic nasal spray, BPL-003, has successfully cleared Phase II trials for treatment-resistant depression, showing robust efficacy data. Analysts predict the asset could reach peak market sales of $1 billio…

1
Pharma and Biotech Daily: AbbVie's Acquisition, Moderna's Flu Vaccine, and More! 1:04

15d ago1:04

1:04

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.AbbVie's acquisition of Capstan Therapeutics for $2.1 billion highlights the increasing trend of mergers and acquisitions in the biopharmaceutical industry. This move gives AbbVie access to Capstan's novel in vivo CAR T the…

1
Reliability Radio EP 327: MAXIMO®: THE DATA FIX • Asset Analytix 13:36

15d ago13:36

13:36

Join Jonathan Guiney on Reliability Radio as he welcomes Sunil Kamerkar, from Asset Analytix. With over 30 years in the business, Asset Analytix specializes in helping Maximo® users transform their operations, focusing on data quality, PM job plan optimization, and strategic program assessments. Sunil explains their partnership with Reliabilityweb'…

1
Reliability Radio EP 326: Africa, Reliability Rising • Natascha Heyman 9:40

15d ago9:40

9:40

Join Jonathan Guiney on Reliability Radio as he speaks with Natascha Heyman, Director of WIRAM Africa (Women in Reliability and Asset Management). Natascha shares her inspiring story of joining WIRAM and her vision for accelerating the organization's exposure across Africa. She highlights ongoing, impactful projects like the Grand Ethiopian Renaiss…

1
Pharma and Biotech Daily: Supreme Court Ruling, Depression Drug Updates, and FDA Decisions 1:02

16d ago1:02

1:02

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The Supreme Court ruled in favor of Gilead in an HIV prevention case, leaving decisions on coverage of the pre-exposure prophylaxis drug to a task force led by RFK Jr. A depression drug missed its phase II endpoint but show…

1
Pharma and Biotech Daily: Navigating the Latest News in the Industry 0:54

19d ago0:54

0:54

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former FDA official Peter Marks criticized the agency's new risk-based COVID-19 vaccine framework, stating it contradicts the administration's transparency and science standards. The CDC's advisory committee recommended M…

1
Pharma and Biotech Daily: Your Essential Dose of Industry News 2:07

20d ago2:07

2:07

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The CDC's new vaccine advisors are meeting with an unexpected agenda today, including discussions on topics such as Sanofi and Gilead's protein degrader deals, the FDA's review of Sarepta's gene therapy, and a contentious h…

1
Pharma & Biotech Daily: FDA Leadership Turnover and Industry Challenges 0:59

22d ago0:59

0:59

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The FDA's Center for Drug Evaluation and Research (CDER) head, Jacqueline Corrigan-Curay, is leaving the agency in July, becoming the latest in a series of FDA leaders to depart. Eli Lilly is facing concerns about gastro…

1
Navigating Regulatory Uncertainty: Updates from the Pharma and Biotech World 1:10

23d ago1:10

1:10

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.Nicole Verdun has exited the FDA as CBER director, allowing Vinay Prasad to consolidate power within the agency. Prasad is seen as a stabilizing and trustworthy figure within the rapidly changing FDA, especially since the d…

1
Breaking News in Pharma and Biotech: Gilead's Yeztugo Approval, Biopharma Deal Premiums, BioNTech-CureVac Merger, and AI in Precision Oncology 0:46

26d ago0:46

0:46

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Gilead has received approval for a twice-yearly HIV drug, Lenacapavir, which will be marketed as Yeztugo, potentially redefining the prep market. In other news, biopharma deal premiums show intense negotiations, with Sano…

1
Biotech Buzz: Financial Challenges, Mergers, and Strategic Shifts in the Pharma World 1:51

27d ago1:51

1:51

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Ey's 2025 Biotech Beyond Borders report reveals that over one-third of biotech companies have less than a year of cash left, indicating financial challenges within the industry. The report emphasizes the need for a return…

1
Pharma and Biotech Daily: Stay Informed on Industry Trends and M&A Activity! 0:46

28d ago0:46

0:46

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Eli Lilly's acquisition of Verve Therapeutics for $1.3 billion has sparked interest in the gene editing space, with analysts speculating on potential market boosts. Recent M&A activity in the biopharma sector has acceler…

1
Pharma and Biotech Daily: Sarepta's Setback, Sage's Success, and Promising Developments Ahead 0:48

29d ago0:48

0:48

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sarepta Therapeutics faced a drop in shares due to a second death from acute liver failure in a patient receiving their DMD gene therapy. On the other hand, Sage Therapeutics had a positive outcome with a $795 million acqu…

1
Vaccine Skeptics, AI Bets, and Industry Challenges: The Pharma and Biotech Daily Update 0:58

1M ago0:58

0:58

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Two new members of Kennedy's revamped CDC vaccine advisory committee, Martin Kulldorff and Robert Malone, have a history of being paid expert witnesses in vaccine cases against Merck. They are known for being vaccine skep…

1
The Latest in Pharma and Biotech: CDC Shake-Ups, Vaccine Controversies, and New Approvals 1:21

1M ago1:21

1:21

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.The CDC has reinstated around 460 employees who were previously fired, with the rehired staff working on viral disease prevention efforts and sexual health testing labs. This comes amid protests and shake-ups at the agency,…

1
Pharma and Biotech Daily: Your Essential Morning Update on the Industry 1:56

1M ago1:56

1:56

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The American Medical Association is calling for a Senate probe into RFK Jr. after he removed all 17 members of the CDC's vaccine advisory board. They are also urging an immediate reversal of the HHS Secretary's decision. …

1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates 1:05

1M ago1:05

1:05

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Robert F. Kennedy Jr.'s removal of all members of the CDC's Advisory Committee on Immunization Practices has raised concerns about the upcoming meeting later this month. Analysts fear that the committee may become more sy…

1
Pharma and Biotech Daily: Weight Loss Breakthroughs, Vaccine Advisor Shakeups, and RNA Therapeutics Expansion 1:24

1M ago1:24

1:24

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Metsera's new long-acting amylin injection, met-233i, has shown promising weight loss results over eight months, leading to a rise in shares. Meanwhile, CDC vaccine advisors are either being pushed out or leaving their p…

1
Reliability Radio EP 325: Future-Proofing Real Estate, Data, Art, and Spaces 12:52

1M ago12:52

12:52

Join Jonathan Guiney and Brendon Russ on Reliability Radio as they chat with Jim Barlow, Solution Strategy at JLL Technologies, live from TRIRIGAWorld. Jim unpacks the major themes shaping global real estate, including the current market contraction and the projected 30 million square feet of corporate space leaving US portfolios. Discover how lead…

1
Pharma and Biotech Daily: Your Essential Update on the Latest Developments 2:40

1M ago2:40

2:40

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.##News 1: FDA approves new drug for treatment of rare genetic diseaseIn a significant development for the rare disease community, the FDA has approved a new drug for the treatment of a rare genetic disease. The drug, whic…

1
Reliability Radio EP 324: Trades Gap: The Book -Dave Reiber & Rich McInnes 16:54

1M ago16:54

16:54

Join Jonathan Gagne and Brendan Russ on Reliability Radio as they sit down with passionate industry experts Dave Reiber from Reliabilityweb and Rich McInnes from Net Results. This episode dives deep into the urgent issue of the skilled trades gap – a "big hole that's getting bigger." Dave and Rich reveal the motivation behind their upcoming book, d…

1
Pharma and Biotech Daily: Lawsuits, Regulatory Progress, and Market Moves 0:57

1M ago0:57

0:57

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Fired employees from the Department of Health and Human Services are suing Robert F. Kennedy Jr. and Elon Musk, claiming their terminations were based on inaccurate and error-ridden information. The lawsuit alleges that HH…

1
Biotech Buzz: The Latest in Pharma and Biotech News 2:00

1M ago2:00

2:00

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in the Pharma and Biotech world.Jefferies predicts an increase in small tuck-in deals in the biotech industry as companies face challenges accessing capital. Companies and industry groups are offering solutions to mitigate the impact of Trump tariff…

1
Pharma and Biotech Daily: Roche and Jazz's Promising Lung Cancer Combo, Trump's Tariffs Impact, and BioAgilytix's Drug Production Capabilities at BIO International 1:11

1M ago1:11

1:11

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Roche and Jazz Pharmaceuticals presented data at ASCO showing that their drug combination improved survival in a phase III lung cancer trial, with analysts noting a strong treatment effect. Jazz has filed for FDA approva…

1
Pharma and Biotech Daily: Key Updates in the World of Pharmaceuticals and Biotechnology 1:33

1M ago1:33

1:33

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron's shares have dropped due to the failure of their dupixent follow-up drug, while Sanofi has acquired Blueprint for $9.5 billion to expand their rare disease portfolio. Bristol Myers Squibb is collaborating with …

1
Pharma and Biotech Daily: Catching up on the Latest in the Industry 0:47

1M ago0:47

0:47

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.The Summit's bispecific drug missed the survival endpoint in a global Phase III trial, but analysts remain optimistic about its potential to appeal to both Eastern and Western patient populations. Sanofi and Regeneron saw…

1
Pharma and Biotech Daily: Top News in Gene Therapy, Vaccine Contracts, and Industry Updates 0:51

2M ago0:51

0:51

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.## Intellia reported an adverse event in its gene therapy trial, causing its stock to drop, adding to existing safety concerns in gene therapy. Analysts downplayed the event, but patient deaths in other trials have raised…

1
Pharma and Biotech Daily: Insider Trading, R&D Spending, and Acquisitions in the World of Pharmaceuticals 1:59

2M ago1:59

1:59

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Former Chinook board member, Rouzbeh Haghighat, has been indicted for insider trading related to Novartis' $3.2 billion acquisition of the company. Despite this scandal, pharma R&D spending increased in 2024, climbing 1.5…

1
Pharma and Biotech Daily: Navigating the Complexities of mRNA Technology and Gene Therapies 1:42

2M ago1:42

1:42

Good morning from Pharma and Biotech Daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.A patient death has led to the halt of Rocket's gene therapy trial for Danon disease, due to complications from an acute systemic infection. This incident highlights the unpredictable nature of gene therapies and may pose…

1
Reliability Radio EP 323: From Icebergs to AI, MaxTAF’s Journey to MaximoWorld 11:15

2M ago11:15

11:15

In this episode of Reliability Radio, host Jonathan Guiney sits down with Alexander Delic and Karolina Szymanska from MaxTAF at MaximoWorld. From flight cancellations and unexpected layovers to breakthrough tech sessions on generative AI, this episode is packed with real stories and real innovation. MaxTAF is on a mission to bring AI-powered produc…

1
Pharma and Biotech Daily: Navigating Turbulent Times in the Biopharma Industry 0:50

2M ago0:50

0:50

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. The biopharma industry is currently facing challenges such as tariff threats and regulatory upheaval. The market has been described as 'moribund' with the need for companies to survive in these tough times. Recent top st…

1
Pharma and Biotech Daily: Your Daily Dose of What Matters in the Industry 1:07

2M ago1:07

1:07

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.A court has halted the Trump administration's plans to reduce and lay off employees in government agencies, citing a lack of authority. Meanwhile, a report called "Make American Healthy Again" criticizes pharmaceutical lobb…

1
Pharma and Biotech Daily: Stay Informed on the Latest Industry Updates 0:58

2M ago0:58

0:58

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Sanofi has acquired Vigil for $470 million upfront, sparking interest in the Alzheimer's target Trem2 following previous failures. The FDA is encouraging states to import drugs from Canada to alleviate drug shortages. In o…

1
Survival Strategies and Strategic Partnerships: The Latest in Pharma and Biotech 1:45

2M ago1:45

1:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Moderna has withdrawn its application for a combination flu and COVID-19 vaccine after discussions with the FDA. The vaccine had shown efficacy in eliciting antibodies, but the company decided to pull the application. In …

1
Pharma and Biotech Daily: Pfizer's $6 Billion Bet, CRISPR Baby Success, and Bio-Rad's Antibody Discovery Platform 1:10

2M ago1:10

1:10

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. Pfizer has made a $6 billion bet on acquiring 3SBio's PD-1/VEGF antibody, despite being a late entrant to the space. This deal comes after Pfizer's partnership with Summit Therapeutics, causing some confusion about the p…

1
Reliability Radio EP 322: Smart Before Fast, David Armstrong 11:32

2M ago11:32

11:32

First get smart, then get quick. Dave Armstrong of Cohesive joins Reliability Radio live at MaximoWorld 2024 to talk digital integration, smarter asset strategies, and how to unlock serious ROI in Maximo Application Suite. With all our technology that we have available, we still struggle at getting it all in one place. We hear about concepts such a…

1
Pharma and Biotech Daily: Navigating the Latest Industry News and Challenges 1:45

2M ago1:45

1:45

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world.Regeneron has acquired ownership of 23andme for $256 million, promising to comply with consumer privacy policies. Makary's proposed rare disease pathway has sparked hope but raised questions among experts. At the American…

1
Novo Nordisk CEO Lars Fruergaard Jorgensen to Depart Amid Share Decline: Pharma and Biotech Daily Update 0:32

2M ago0:32

0:32

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world. Novo Nordisk CEO Lars Fruergaard Jorgensen is set to depart as the Danish pharma company's shares have been on a decline. During Jorgensen's eight-year tenure, the company saw significant growth in sales, profits, and shar…

1
Pharma and Biotech Daily: Senate Hearings, Accelerated Approvals, and Big Investments 1:13

2M ago1:13

1:13

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma e Biotech world.At a recent U.S. Senate hearing, Health and Human Services Secretary was questioned about cuts being made to the department and his stance on endorsing the measles vaccine during a growing outbreak. The hearing was tense at…

1
Pharma and Biotech Daily: Breaking News and Innovations in Healthcare 2:31

2M ago2:31

2:31

Good morning from Pharma and Biotech daily: the podcast that gives you only what's important to hear in Pharma and Biotech world. ## Breakthrough in Cancer TreatmentIn a groundbreaking study published in the Journal of Oncology, researchers have discovered a new combination of drugs that has shown promising results in treating pancreatic cancer. Th…